Topics

Toyo Seikan Group Holdings, Ltd. (TSE:5901, "Toyo Seikan Group") has entered into the agreement to invest in NovoTec Group Pte. Ltd. ("NovoTec", Director: J. Edward Sang, Ph.D.), a Singapore-based start-up company that aims to improve medical services in Southeast Asia etc. by establishing a hospital service platform.

Issue in Southeast Asia healthcare

In Southeast Asia etc., there are differences in accessible medical services by region, and many patients are unable to receive the medical care they need. The demand for quality medical services is expected to increase further in the future due to population growth and aging in the region.

What we aim to through this investment

Through our investment in NovoTec, which is engaged in the development and stable supply of medical services and products in Southeast Asia etc., we will work together to address this issue and create business opportunities in the healthcare field, which is one of the areas to focus on in the future. At the same time, we explore opportunities to enter the healthcare product market in those regions.

From left: Ichio Otsuka (President and Representative Director of Toyo Seikan Group), J. Edward Sang, Ph.D. (Director of NovoTec)

Click here for details(PDF).

For inquiries about this press release, please contact:
Mr. Kodai Nakanori at Corporate Communication Group
tskg_contact@tskg-hd.com